Evidence map›Paper›PMID 31623341›Full record

ArticlePharmaceutics2019

Development of a Mucoadhesive

Barbara Vigani, Angela Faccendini, Silvia Rossi, Giuseppina Sandri, Maria Cristina Bonferoni, Pietro Grisoli, Franca Ferrari

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Fabrication and characterization of bioprints with Lactobacillus crispatus for vaginal application.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Barbara ViganiDepartment of Drug Sciences, University of Pavia, V.le Taramelli, 12, 27100 Pavia, Italy. barbara.vigani@unipv.it.
Angela FaccendiniDepartment of Drug Sciences, University of Pavia, V.le Taramelli, 12, 27100 Pavia, Italy. angela.faccendini01@universitadipavia.it.
Silvia RossiDepartment of Drug Sciences, University of Pavia, V.le Taramelli, 12, 27100 Pavia, Italy. silvia.rossi@unipv.it.
Giuseppina SandriDepartment of Drug Sciences, University of Pavia, V.le Taramelli, 12, 27100 Pavia, Italy. giuseppina.sandri@unipv.it.
Maria Cristina BonferoniDepartment of Drug Sciences, University of Pavia, V.le Taramelli, 12, 27100 Pavia, Italy. cbonferoni@unipv.it.
Pietro GrisoliDepartment of Drug Sciences, University of Pavia, V.le Taramelli, 12, 27100 Pavia, Italy. pietro.grisoli@unipv.it.
Franca FerrariDepartment of Drug Sciences, University of Pavia, V.le Taramelli, 12, 27100 Pavia, Italy. franca.ferrari@unipv.it.
University of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Local administration of vaginal probiotics, especially lactobacilli, has been recently proposed as an effective prevention strategy against candidosis recurrences, which affect 40-50% of women. In this context, the aim of the present work was the development of a mucoadhesive

Indexed as

in situ thermogelling vehicleL. gasserimethylcellulosemucoadhesionpectinpoloxamervaginal candidosisxyloglucan

Identifiers

PMID31623341
PMCPMC6836057
OpenAlexW2978873298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.